FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) The question of what would happen when
Read More(By Juliette Cubanski and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) The question of what would happen when
Read More(By MaryBeth Musumeci, Robin Rudowitz, and Tricia Neuman for Kaiser Family Foundation published June 10, 2021) President Biden’s FY 2022
Read More(By Morgan Haefner for Becker’s Hospital Review) A new law in Louisiana will bar health insurers from implementing a pharmacy
Read More(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation published June 8, 2021) The Medicare Part D program provides
Read More(By Lev Facher for STAT) WASHINGTON — State lawmakers in Oregon have tried to lower high drug prices from nearly
Read MoreMedicare is supposed to cover the COVID-19 vaccine itself with no out-of-pocket costs; however, providers can charge extra for additional
Read More(By Maia Anderson for Becker’s Hospital Review) Walmart is now offering a prescription drug savings program to members of its Walmart+ program,
Read MoreThe House passed the Fairness in Orphan Drug Exclusivity Act (H.R. 1629) to fix the nation’s orphan drug development rules
Read More(By Katie Adams for Becker’s Hospital Review) Medicare is not providing adequate cost savings for the millions of Americans who take
Read MoreIf you are 65 and still working, the rules for Medicare enrollment will depend partly on whether your employer is
Read More